First Comparison of Amulet and Watchman FLX LAA Closure Devices

Results from the SWISS-APERO Trial reported at TCT 2021 and published simultaneously in Circulation

Diagnostic and Interventional Cardiology

First Comparison of Amulet and Watchman FLX LAA Closure Devices Found Similar Outcomes

Structural Heart Occluders

TCT DAIC

Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device

Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX LAAC Device

Diagnostic and Interventional Cardiology

TCT DAIC

Left Atrial Appendage (LAA) Occluders

Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX LAAC Device

Cleveland Clinic-Led Trial Finds that Atrial Fibrillation Patients Undergoing TAVR and Watchman Procedures Together Have Similar Outcomes to Using Blood Thinners after TAVR

Data at Heart Rhythm 2023 Highlight Key Boston Scientific Therapies

TCT DAIC

Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device